Which diabetes startups received Gates Foundation grants since 2015?

1. Public database exists — but you must search it for specifics

The Bill & Melinda Gates Foundation maintains a committed grants database that contains grant commitments from 1994 onward and is the authoritative source to identify grantees and amounts; any investigator seeking a list of diabetes startups funded since 2015 must query that database for diabetes- or startup-related keywords or download and filter the dataset ^[1].

2. No supplied source enumerates diabetes startups awarded grants since 2015

Among the documents and links you provided, none present a compiled list of Gates grants to diabetes startups after 2015. The materials include the foundation’s grants portal ^[1], scattered grant entries (e.g., an April 2015 entry INV-009063), and background coverage about foundation priorities ^[2], but they do not identify specific diabetes startups that received Gates funding since 2015 ^{[1] [4] [2]}.

3. Gates has funded diabetes-related work and U.S. health grants grew — context matters

Reporting indicates the foundation’s U.S. grantmaking on health areas, including obesity and Type 2 diabetes, expanded in recent years, with cited U.S. grant totals rising to $44 million in 2021 and $24 million in 2022 in one profile about health philanthropy — a sign the foundation has been investing more domestically on metabolic disease ^[3]. That growth makes it plausible some diabetes-focused organizations, possibly including startups, were funded — but the supplied pieces do not name recipients ^[3].

4. Early and adjacent examples in the public record are not the same as post‑2015 startup grants

Older and tangential items in your search results show Gates involvement in diabetes-related research partnerships (for example, a 2015 Forbes article referencing collaboration around an experimental vaccine trial and other philanthropic support), but that story concerns collaborations with hospitals and foundations rather than a clear Gates grant to a diabetes startup ^[5]. Use caution equating any diabetes research mention with Gates grants to startups without explicit grant entries in the Gates database ^{[5] [1]}.

5. How to get a definitive answer — a practical roadmap

To compile a reliable list: (a) run targeted queries on the Gates committed grants database for terms such as “diabetes,” “type 1,” “type 2,” “glucose,” “metabolic,” and filter by date from 2015–present ^[1]; (b) cross-check candidate grantee names against company registries and press releases to distinguish academic labs and NGOs from commercial startups ^{[1] [2]}; (c) review the details in each grant record (amount, purpose, recipient type) before labeling an entity a “startup” ^[1]. The database is the primary source and must be searched to produce a definitive list ^[1].

6. Biases, hidden agendas and limitations in the available reporting

Foundation summaries and third‑party profiles emphasize major thematic shifts and aggregate dollar figures ^{[3] [2]}. These narratives can obscure whether grants went to nonprofits, academic groups, for‑profit startups, or programmatic initiatives. The Gates database itself excludes certain internal or sensitive items and focuses on committed grants, so absence of evidence in secondary reporting does not prove absence of such grants — only that the supplied sources here do not document them ^{[1] [2]}.

7. Bottom line for your query

Available sources you provided do not name which diabetes startups, if any, received Gates Foundation grants since 2015; the correct next step is to query the Gates committed grants database directly and then validate any candidate grantees against external corporate and press records before drawing conclusions ^{[1] [3]}.